Acrivon Therapeutics (ACRV) Appoints Charles Baum to its Board

Go back to Acrivon Therapeutics (ACRV) Appoints Charles Baum to its Board
(NASDAQ: ACRV) Delayed: 2.20 -0.19 (7.95%)
Previous Close $2.39    52 Week High
Open $2.33    52 Week Low
Day High $2.37    P/E N/A 
Day Low $2.17    EPS
Volume 499,427